GP
PFE icon

Guardian Partners’s Pfizer PFE Stock Holding History

Guardian Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.91M Buy
67,721
+316
+0.5% +$8.41K 0.16% 89
2025
Q4 		$1.8M Buy
67,405
+100
+0.1% +$2.52K 0.14% 99
2025
Q3 		$1.83M Buy
67,305
+10
+0% +$247 0.16% 93
2025
Q2 		$1.72M Sell
67,295
-79,416
-54% -$1.85M 0.15% 97
2025
Q1 		$3.28M Buy
146,711
+18,060
+14% +$473K 0.34% 74
2024
Q4 		$3.46M Buy
+128,651
New +$3.49M 0.35% 69

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Guardian Partners's PFE Position: Q1 2026 in Review

Guardian Partners increased its Pfizer (PFE) stake by 0.47% in Q1 2026, buying an estimated $8.41K and bringing the position to 67,721 shares worth $1.91M. The position accounts for 0.16% of the portfolio, ranked #89.

Guardian Partners first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.46M in Q4 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Guardian Partners held 67,721 shares of Pfizer worth $1.91M as of Q1 2026.
  • Guardian Partners bought 316 Pfizer shares in Q1 2026, an estimated $8.41K.
  • Pfizer made up 0.16% of Guardian Partners's portfolio in Q1 2026, its #89 holding.
  • Guardian Partners first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Guardian Partners's Pfizer position peaked at $3.46M in Q4 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Guardian Partners's 13F filing for Q1 2026, filed 18 May 2026.